HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A case of mosaic tetrasomy 12p (Pallister-Killian Syndrome) diagnosed prenatally: comparison of chromosome analyses of various cells obtained from the patient.

Abstract
A pregnant woman was referred to our hospital at the 29th week of gestation with the symptom of polyhydramnios; diaphragmatic herniation of the fetus was suspected. Fetal chromosome anlaysis was performed using fibroblasts obtained by aminocentesis, and mosaicism of 46,XX and isochromosome of 12p were diagnosed. Out of 50 karyotyped cells, 19 (38.0%) showed the tetrasomy of the isochromosome of 12p. The mother vaginally delivered a baby girl who died just after delivery. The analysis of cord blood lymphocytes revealed only 0.5% incidence of tetrasomy of 12p. The incidence of tetrasomy was 8.0% for the placental chorionic villi, 48.0% for the fibroblasts obtained from the umbilical cord, and 70.0% for the skin fibroblasts. Thus, the diagnosis of Pallister-Killian Syndrome (PKS) is confirmed by mosaicism of i(12p), that is, the affected patients exhibit tissue-specific mosaicism, with the abnormal karyotype expression in limited lymphocytes, but marked in fibroblasts.
AuthorsK Takakuwa, I Hataya, M Arakawa, M Tamura, N Sekizuka, K Tanaka
JournalAmerican journal of perinatology (Am J Perinatol) Vol. 14 Issue 10 Pg. 641-3 (Nov 1997) ISSN: 0735-1631 [Print] UNITED STATES
PMID9605253 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Chromosome Aberrations (diagnosis)
  • Chromosome Disorders
  • Chromosomes, Human, Pair 12 (genetics)
  • Female
  • Fetal Diseases (diagnosis, genetics)
  • Genetic Testing
  • Humans
  • Karyotyping
  • Mosaicism (genetics)
  • Pregnancy
  • Prenatal Diagnosis
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: